Mumps

01Pathophysiology

The mumps virus gains entry through the respiratory mucosa after inhalation of infected droplets or direct contact with contaminated saliva. Initial viral replication occurs in the nasopharyngeal epithelium and regional lymph nodes, which gives rise to a primary viremia. This viremia seeds the virus to multiple target organs, most notably the salivary glands (parotid glands), central nervous system, pancreas, and gonads.

Within the parotid glands, viral replication triggers a robust inflammatory response characterized by interstitial edema, mononuclear cell infiltration, and necrosis of acinar and ductal epithelial cells. This inflammation explains the hallmark bilateral parotid swelling, and the resulting duct compression and tissue distension is why patients report pain that intensifies with salivation, particularly when eating sour or acidic foods (which are potent salivary stimulants). The swelling is severe enough to obscure the angle of the mandible and displace the earlobes, both of which are classic exam findings.

The virus has a well-documented tropism for glandular and neural tissue. This tropism accounts for the range of complications: orchitis develops when the virus involves the testicular interstitium and seminiferous tubules, aseptic meningitis results from direct viral invasion of the meninges, and pancreatitis occurs from infection of pancreatic acinar cells. Importantly, serum amylase rises not only from parotid inflammation but can also rise from pancreatic involvement, so clinical context is needed to distinguish the source.

The elevated serum amylase seen on labs directly reflects glandular inflammation and is a classic early laboratory clue. This value may be elevated even before clinical swelling becomes obvious, making it a useful diagnostic adjunct in ambiguous presentations.

02Classification and Clinical Manifestation

03Diagnostic Workup

The diagnosis of mumps in a classic presentation (a child or young adult with bilateral parotid swelling, fever, and pain with eating) is often made clinically. However, laboratory confirmation is important for public health reporting and in outbreak settings.

Serum amylase is a quick supportive clue but is not confirmatory on its own, because it rises in other conditions involving salivary or pancreatic inflammation. Think of it as a "soft" lab finding that nudges you toward the diagnosis.

The best initial serologic test is mumps IgM antibody. In unvaccinated patients, IgM becomes detectable within 5 days of symptom onset and remains positive for several weeks. However, a critical testing pitfall exists: in previously vaccinated individuals who develop breakthrough mumps, IgM may be negative or only transiently positive because the anamnestic (secondary) immune response may suppress the IgM response. In these patients, reliance on IgM alone will miss the diagnosis.

For this reason, RT-PCR of a buccal swab is the most accurate test and the preferred confirmatory method. It has the highest sensitivity when the swab is collected within the first 3 days of parotid swelling. Public health guidelines recommend collecting both a buccal swab for RT-PCR and a serum sample for IgM simultaneously to maximize diagnostic yield.

If meningitis is suspected clinically (headache, neck stiffness, photophobia), a lumbar puncture should be performed. The CSF profile in mumps meningitis is a lymphocytic pleocytosis with mildly elevated protein and normal to slightly low glucose, a pattern consistent with viral (aseptic) meningitis.

04Management and Treatment

There is no antiviral therapy for mumps. This is a high-yield testing point. Management is entirely supportive, and the emphasis is on symptom relief and isolation to prevent further transmission.

For uncomplicated parotitis, the treatment is straightforward: analgesics, hydration, and a soft diet to minimize pain with chewing. Advise patients to avoid acidic or citrus-containing foods and drinks, as these stimulate salivation and worsen pain.

For orchitis, the priority is comfort and monitoring. The majority of cases resolve without long-term sequelae. Although testicular atrophy may develop in up to 50% of affected testes, bilateral involvement is uncommon, and sterility is rare. This is a frequently tested misconception: students often overestimate the risk of infertility from mumps orchitis.

Isolation for 5 days from the onset of parotid swelling is the standard public health recommendation. The patient is considered infectious from approximately 2 days before symptom onset through 5 days after parotid gland swelling begins.

For prevention, the MMR vaccine is the cornerstone. It is a live attenuated vaccine and is therefore contraindicated in pregnancy, severe immunodeficiency (e.g., advanced HIV with CD4 less than 200), and patients receiving high-dose immunosuppressive therapy. This contraindication is a commonly tested point, especially when a vignette describes a pregnant healthcare worker exposed to mumps.

05Differential Diagnosis and Distractors

The most common trap on exams is confusing mumps parotitis with acute bacterial (suppurative) parotitis. The key differentiators are laterality (bilateral vs. unilateral), patient demographics (child/young adult vs. elderly/debilitated), and the presence of purulent discharge from the duct orifice in the bacterial form.

06Traps and High-Yield Pearls

The most common way students lose points on mumps questions is by selecting orchitis-related infertility as an expected outcome. While orchitis is a well-known complication in post-pubertal males, bilateral involvement is uncommon, and true sterility is rare. Exam writers use this to test whether you understand the actual prognosis versus the exaggerated fear.

A second frequent trap involves the diagnostic approach in vaccinated patients. A previously vaccinated individual who develops parotid swelling may have a negative IgM, because the secondary immune response blunts IgM production. If you rely solely on IgM serology in this scenario, you will miss the diagnosis. The correct answer in this context is RT-PCR of a buccal swab, which remains positive regardless of vaccination status.

Another tested concept is the management of a pregnant woman exposed to mumps. The reflex answer might be to give the MMR vaccine, but the MMR is a live vaccine and is contraindicated in pregnancy. The correct step is observation and supportive care if symptoms develop. There is no effective post-exposure prophylaxis with immunoglobulin for mumps.

Finally, when a vignette mentions elevated amylase in a patient with parotid swelling, do not jump to pancreatitis unless there are abdominal symptoms and an elevated lipase. The elevated amylase in mumps is most often of salivary origin, not pancreatic. Exam writers use this to see whether you reflexively associate amylase elevation with pancreatitis or correctly attribute it to the parotid gland inflammation.

The core competency being tested with mumps questions is your ability to recognize the classic presentation (bilateral parotid swelling in an unvaccinated young patient), select the correct confirmatory test (RT-PCR over IgM in vaccinated individuals), and understand the limitations of both the vaccine (live, contraindicated in pregnancy) and the available treatment (purely supportive, no antiviral).